Atlas Trials

Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer

Clinical trial NCT00459901 · TERMINATED

Trial details

NCT number
NCT00459901
Sponsor
Peter Kozuch
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2004-06-01
Primary completion
2005-06-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.